Former BridgeBio exec launches new anti-inflammatory biotech with $169M, but is mum on what exactly it's doing

Lei Lei Wu

News Reporter

Paragon Therapeutics, an antibody engineering company, has spun out its anti-inflammatory antibodies into Apogee Therapeutics, which launched out of stealth Wednesday morning with a Series …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Former BridgeBio exec launches new anti-inflammatory biotech with $169M, but is mum on what exactly it's doing

Lei Lei Wu

News Reporter

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

FDA inspectors discover trucks carrying torn-up records leaving Indian generics factory

Exclusive: Flagship-backed Valo Health loses interim CEO ahead of key Phase 2 readout

Edgewise’s stock surges as heart drug passes early safety test

Lasker Award goes to three scientists who pioneered research behind GLP-1 drugs

Stem cell startup spun out of George Church’s lab raises $75M

Breaking down silos with a new quantitative approach to drug development

For­mer Bridge­Bio ex­ec launch­es new an­ti-in­flam­ma­to­ry biotech with $169M, but is mum on what ex­act­ly it's do­ing

News Reporter

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Former BridgeBio exec launches new anti-inflammatory biotech with $169M, but is mum on what exactly it's doing